VOYA Investment Management
ACOR

VOYA Investment Management’s Acorda Therapeutics ACOR Stock Holding History

VOYA Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-221
Closed -$25K – 2660
2020
Q1 		$25K Sell
221
-1,282
-85% -$252K ﹤0.01% 2576
2019
Q4 		$368K Buy
1,503
+681
+83% +$172K ﹤0.01% 2064
2019
Q3 		$283K Buy
822
+307
+60% +$167K ﹤0.01% 2074
2019
Q2 		$474K Buy
515
+137
+36% +$168K ﹤0.01% 1823
2019
Q1 		$603K Buy
378
+64
+20% +$115K ﹤0.01% 1667
2018
Q4 		$586K Buy
314
+4
+1% +$8.7K ﹤0.01% 1625
2018
Q3 		$732K Hold
310
– – ﹤0.01% 1604
2018
Q2 		$1.07M Sell
310
-11
-3% -$33.7K ﹤0.01% 1346
2018
Q1 		$910K Sell
321
-7
-2% -$21K ﹤0.01% 1438
2017
Q4 		$845K Sell
328
-5
-2% -$14.2K ﹤0.01% 1521
2017
Q3 		$944K Buy
333
+161
+94% +$424K ﹤0.01% 1473
2017
Q2 		$406K Buy
172
+16
+10% +$31.7K ﹤0.01% 1969
2017
Q1 		$393K Hold
156
– – ﹤0.01% 1869
2016
Q4 		$352K Sell
156
-11
-7% -$26.2K ﹤0.01% 1958
2016
Q3 		$418 Sell
167
-6
-3% -$17.9K ﹤0.01% 1832
2016
Q2 		$528K Sell
173
-1,073
-86% -$3.49M ﹤0.01% 1675
2016
Q1 		$3.96M Sell
1,246
-640
-34% -$2.66M 0.01% 815
2015
Q4 		$9.69M Sell
1,886
-954
-34% -$4.17M 0.02% 567
2015
Q3 		$9.04M Sell
2,840
-2,544
-47% -$9.87M 0.02% 596
2015
Q2 		$21.5M Buy
5,384
+106
+2% +$409K 0.05% 333
2015
Q1 		$21.1M Buy
5,278
+609
+13% +$2.79M 0.05% 348
2014
Q4 		$22.9M Buy
4,669
+101
+2% +$433K 0.05% 339
2014
Q3 		$18.6M Sell
4,568
-209
-4% -$784K 0.04% 374
2014
Q2 		$19.3M Sell
4,777
-400
-8% -$1.63M 0.04% 377
2014
Q1 		$23.5M Buy
5,177
+271
+6% +$1.1M 0.05% 310
2013
Q4 		$17.2M Buy
4,906
+1,018
+26% +$3.97M 0.04% 392
2013
Q3 		$16M Buy
3,888
+384
+11% +$1.65M 0.04% 390
2013
Q2 		$13.9M Buy
+3,504
New +$14.4M 0.04% 421

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VOYA Investment Management's ACOR Position: Q2 2020 in Review

VOYA Investment Management sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 221 shares — an estimated $25K sold.

VOYA Investment Management first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $23.5M in Q1 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • VOYA Investment Management reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • VOYA Investment Management sold 221 Acorda Therapeutics shares in Q2 2020, an estimated $25K.
  • VOYA Investment Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • VOYA Investment Management's Acorda Therapeutics position peaked at $23.5M in Q1 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on VOYA Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.